-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Kazia Therapeutics (KZIA)
-
-
-
-
-
-
-
Kazia Therapeutics licenses PD-L1 protein degrader for cancer treatment
-
-
-
-
-
-
-
Kazia Therapeutics (KZIA) and the Hebrew University of Jerusalem Receives a Grant from The Michael J. Fox Foundation
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Kazia Therapeutics (KZIA)
-
-
-
413,571 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

